170
Participants
Start Date
May 20, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Degludec insulin
The pre-mixed human insulin or insulin analogues were stopped, and the treatment was switched to Delgol insulin liraglutide injection. The initial dose was subcutaneous injection of 80% (not more than 16 units) of the full daily dose of medium-acting insulin in the original insulin, once a day, and the dose of Delgol insulin liraglutide injection was adjusted according to the fasting blood glucose level. Example 1: If the patient is currently using Novorin 30 20iu bid, the conversion calculation is 40\*70%\*80%=22.4 units, which should be 16 units; In example 2, the patient applied eubrine 50 20 IU bid, and the conversion calculation was 40\*50%\*80%=16 units.
continuous glucose monitoring system（CGMS）, Beijing
Taizhou First People's Hospital
OTHER
Wenzhou Central Hospital
OTHER
Wenzhou People's Hospital
OTHER
Chaohu Hospital of Anhui Medical University
OTHER
Affiliated Zhoushan Hospital of Wenzhou Medical University
OTHER
Yiwu Central Hospital
OTHER
Jinhua Municipal Central Hospital
OTHER
Dongyang People's Hospital
OTHER
The Central Hospital of Lishui City
OTHER
Affiliated Hospital of Jiaxing University
OTHER
Jinhua People's Hospital
OTHER
Wuhu City Second People's Hospital
OTHER
Affiliated Hospital of Nantong University
OTHER
Beijing Tsinghua Chang Gung Hospital
OTHER